Innovating Works

NEUROCONN GMBH

Desconocido
FRESCO4NoPain: Frontier RESearch COmpetences for Neuro modulation and Oscillations in Pain NEUROCONN GMBH participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Chronic pain is a major societal and economic European burden, affects one in five adults, and its inadequate relief indicates a major unmet...
2024-06-26 - 2029-01-31 | Financiado
PAINLESS: Pain relief in palliative care of cancer using home based neuromodulation and predictive biomarkers NEUROCONN GMBH participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 More than 50% of cancer patients develop pain before death: 80% can be treated with drugs, but 20% show a low response or have serious adver...
2022-05-20 - 2027-05-31 | Financiado
EMEREEG: A portable device for Early detection and treatment of Traumatic Brain Injury based on advanced qEEG... NEUROCONN GMBH participó en un FP7: Traumatic Brain Injury (TBI) is recognized as a major public health concern, especially for teenagers and young adults, since it can lead to...
Financiado
MATRICS: Multidisciplinary Approaches to Translational Research In Conduct Syndromes NEUROCONN GMBH participó en un FP7: Conduct Disorder (CD) is the key paediatric disorder characterized by severe aggression. It is heterogeneous, and our understanding of the n...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.